Merck today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for RECARBRIO™ (imipenem, cilastatin, and relebactam) to treat...

The Los Angeles County Health Department (LAC DPH) has identified 2 cases of Enterobacter cloacae bloodstream infections in persons who received non-FDA approved stem cell injections, prompting the issuance...